Inovio制药

INO NASDAQ
2.620
+0.040
+1.55%
交易中 15:34 06/18 EDT
开盘
2.590
昨收
2.580
最高
2.700
最低
2.580
成交量
50.13万
成交均量(3M)
107.76万
52周最高
6.30
52周最低
2.150
换手率
0.51%
市值
2.57亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Inovio制药 INO股票价格,Inovio制药股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Inovio Pharmaceuticals, Inc. (Inovio) is a clinical-stage pharmaceutical company, which is involved in developing deoxyribonucleic acid (DNA) immunotherapies and vaccines focused on treating and preventing cancers and infectious diseases. The Company's DNA-based immunotherapies, in combination with its electroporation delivery devices, generates immune responses, in particular T cells, in the body to fight target diseases. It has completed, current or planned clinical programs of its SynCon immunotherapies for human papillomavirus (HPV)-caused pre-cancers and cancers, influenza, prostate cancer, breast/lung/pancreatic cancer, hepatitis C virus (HCV), hepatitis B virus (HBV), human immunodeficiency virus (HIV), Ebola, Middle East Respiratory Syndrome (MERS) and Zika virus. With its immunotherapy platform, as well as with its CELLECTRA electroporation delivery technology, it has a pipeline of pre-clinical and clinical stage products that have generated in vivo immune responses.
展开 >

最近浏览

名称
价格
涨跌幅